Novel oral combined 17β-estradiol (E2) and micronized progesterone (P4) therapy improves vasomotor symptoms (VMS) and sleep in postmenopausal women (PW)
2018 ◽
Vol 132
(1)
◽
pp. 161-170
◽
2019 ◽
Vol 26
(5)
◽
pp. 506-512
◽
2003 ◽
Vol 10
(6)
◽
pp. 516-521
◽
2014 ◽
Vol 21
(3)
◽
pp. 227-235
◽
Keyword(s):
2018 ◽
Vol 73
(11)
◽
pp. 630-632
2012 ◽
Vol 19
(8)
◽
pp. 886-893
◽